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Chapter 15
Do environmental or genetic factors contribute
to the risk of getting Buruli ulcer?
Buruli ulcer disease, caused by Mycobacterium ulcerans, is emerging in
West Africa. After a brief introduction in chapter 1, a review of the
clinical featnres of Buruli ulcer clisease is given in chapter 2. It is
assumed that a significant proportion of the population living in an
endemic area - and exposed to M. ulceratts - never develop Buruli ulcer
disease. Genetic or environmental factors explaining the development
of Buruli ulcer disease once individuals have been infected with
M. tilcerttns, are discussed. The hypothesis that schistosomiasis is a
risk factor for Buruli ulcer disease was based on the following consid-
erations. In the years following the construction of the Akosombo
dam in 1964, the prevalence of schistosomiasis has increased in areas
around Lake Volta. In the same period Buruli uicer disease emerged
in the same areas. An increased helminthic infectious burden might
conceivablv cause a switch in the immune system in human hosts, i.e.,
changing the immune response pattern from a Th1 to a Th2 type,
making them more suscept ible for mycobacter ial  infect ion.
Furthermore, possible gerretic host susceptibility factors for Buruli
ulcer that are relevant in other mycobacterial diseases are discussed.
Healing disease stages in Buruli ulcer may be accompanied by a
protective (Th1 type) immune response, as was studied in chapter 3.
A cellular Th-1-type immune response with high levels of 65arnma
interferon (IFN-y) is regarded as crucial for the host defence against
mycobacteria, whereas interleukin-4 (IL-4), IL-5 suggest a Th-2-type
immune response; and IL-10 suggest blunting of immtrne response
now believed to be controlled by T regulatory cells. Of the 39 Buruli
ulcer patients inclucled, 23 patients were in the early disease stage,
and 16 in the late disease stage. As controls, 39 healthy Chanaian
subjects participated. Early-stage Buruli ulcer patients produced sig-
nificantly lower levels of IFN-y and IFN-y/IL-4 ratios compared to
late-stage Buruli ulcer patients. IL-10 and IL-4 production did not dif-
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a longitudinal study design, the differences in Th1-type cytokine pro-
duction between early- and late-stage Buruli ulcer rnight reflect an
improved immune defense over time.
The hypothesis on schistosomiasis as a risk factor for Buruli ulcer
was tested in chapter 4. One hundred six out of 159 patients with con-
firmed Buruli ulcer and 106 matched community controls were
included in the study, in which circulating anodic antigen was meas-
ured by detecting circulating anodic antigen in serum. No difference
in detection rates and worm burden among patients and matched
controls was founcl. These results do not support the hypothesis that
susceptibility to Buruli ulcer is driven by a co-infection with schisto-
somes.
In chapter 5, we investigated the role of SLC1|A1 (NRAMPI) in
Buruli ulcer because of its associations with other mycobacterial infec-
tions, such as tuberculosis and leprosy. In total 182 Buruli ulcer
patients and 191 healthy neighborhood-matched controls in Chana
were enrolled and tested for three polymorphisms in the SLC1J'47
gene, one of which was the D543N. The D543N polymorphism was
significantly associated with Buruli ulcer: the odds ratio (adjusted for
gender, age, and region of the participant) of the CA genotyPe versus
the GG genotype was genotype was 2.9 (95%CL7.41-5.91). These data
lend support to a role in susceptibility of the polymorphisrn in the
SLCllA1 gene in developing Buruli ulcer disease in Ghana, with an
estimated 13% population attributable risk.
Difficulties in diagnosing Buruli ulcer; what can
Polymerase Chain Reaction (PCR) add to solve this problem?
Laboratory confirmation of Buruli ulcer is complicated as no "gold
standard" for diagnosis exists. A nested primer PCR based onlS2404
has shown promise as a diagnostic assay. In chapter 6, we evaluated
this PCR to detect M. ulcerans DNA it-t tissue specimens from 143
Buruli ulcer patients in Ghana. Comparisons were made with culture
and histopathology results. Of all 143 specimens,107 (74.8%) showed
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Chapter  I  5
the presence of M. ulcerans DNA by PCR. Detection rates were influ-
enced neither by the amount of tissue processed for PCR nor by the
stage (pre-ulcerative or ulcerative) of disease. For future studies, small
tissue samples, e.g., punch biopsy samples, might be sufficient for
case confirmation. A letter to the Editor stressing the need of inclusion
of Buruli ulcer disease in the differential diagnosis of ulcerative
lesions is presented in chapter 7.
Impact on daily life:
Which cultural and religious factors determine how people deal
with Buruli ulcer once they contract it? Which factors are associat-
ed with functional limitations and subsequent employment or
schooling in Buruli ulcer patients? How can these functional limi-
tations be evaluated? Are there differences in treatment outcome
between hospitals?
The purpose of the study in chapter 8 was to explore the beliefs and
attitudes of people in Chana towards Buruli ulcer. Quantitative and
qualitative data were obtained in Ghana by interviewing patients
with this disease and control subjects. Common perceived causes
were witchcraft and curses. Financial difficulties, fear of the mutilat-
ing aspects of surgery, and social stigma were the main reasons given
for delay in obtaining treatment. Patients are reluctant to seek treat-
ment outside their own community. The stigma of the disease is huge,
and is strongly associated with the mysterious nature of the condition,
the lack of knowledge about its mode of transmission, and the lack of
proper treatment. Stigma scores were higher among unaffected
respondents and in a less endemic location. Education on the disease,
usually propagated for early case detection, might be useful in reduc-
ing stigma. Buruli ulcer disease can lead to scarring, calcificatiory and
contractures with permanent disabilities. In chapter 9, 10 and 11 the
development of a Buruli ulcer functional limitation score and its reli-
ability and validity is discussed. In chapter 9, an impression of the
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reduction in range of motion (ROM) of one or more joints (using a
goniometer). In almost 60"h of former Buruli ulcer patients functional
limitations were found. A simplified and functional scoring system
was proposed. Chapter 10 describes the development of ihis scoring
system; the item selection arrd testing of interrral consistency. The reli-
ability and validity of this Buruli ulcer iunctional lirnitation score
(BUFLS) questionnaire was further assessed in chapter 11. Both glob-
al impression and ROM correlated well with the functional limitation
scores. To determine inter-observer reliability, the functional limita-
tion score was reassessed in 107 participants within one to three
weeks after the firsi interview by another interviewer and interpreter.
The inter-observer reliability c>i 107 participants as determined by an
intra-class correlation coefficient was very good. The functional limi-
tation scores measured irr the second assessment were significantly
higher than in the first assessment. This should be taken into account
when the functional limitation score is used for the individual patient.
The BUFLS can be used as for between group comparisons of end-
points in clinical trials and in the planning of resources. Former Buruli
ulcer disease patients are evaluated in chapter 12 to assess tl-re factors
associated with functional limitations and subsequent employment or
schooling. Of the 638 participants in Gl.rana and Benin, almost 60 %
had a functional limitation after a median period of almost 4 years fol-
lowing the treatment for Buruli ulcer. A lesion on a joint, higher age,
female gender, a lesion on a disial part of an extremity and a
persistent wound were found to be independent risk factors for the
development of a functional lirnitation. The same risk factors applied
for stopping occupation or education. Both functional limitations and
financial difficulties due to Buruli ulcer disease often led to iob loss
and school dropout.
A plea for rehabilitation programs is made to diminish the suffering
from the functional limitations and employment or schooling prob-
lems caused by Buruli ulcer.
Treatment effects were assessed in chapter 13 by following up 78
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PatientstreatedforBurul iulcer intwohospitalswithdi f ferenttreat-
Lent aspects, including use of rifampicin' BCG vaccination status'
and widely differing surgical Practices' Of the 33 patients treated 
in
hospital A, six (18d were not healed at follow-up' whereas of the 45
patients treated in hospital 8,21 (47%) were not healed' The length of
,tuy lr-t hospital A *us significantly longer' and more operations 
on
average were done per pitient' Using a logistic regression model 
for
multivariate analysis, only treatment as given in hospital A' with 
stan-
dard practice of wide surgical excision' appeared to predict ulcer 
heal-
ing lndependently. This study shows large differences in treatment
outcome between the two hospitals; the results support the hypothe-
sis that extent of surgical treatment influences the chance of healing 
of
B u r u l i u l c e r . I n c h a p t e r 1 4 t h e n e e d t o i m p r o v e e x i s t i n g t r e a t m e n t
opt ionsisdiscussed,withapleatodevelopbetter(especial lynon-Sur-
gical)  t reatment strategies'
Future per
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